Results 51 to 60 of about 30,642,264 (240)

Validation of replicative phenotyping to detect and assign HIV-1 resistance in clinical specimens [PDF]

open access: yes, 2009
The ability of HIV-1 to develop resistance to antiretroviral drugs has limited the overall efficacy of combination therapy to suppress viral replication.
Louvel, Séverine
core   +1 more source

HIV DNA reservoir and elevated PD‐1 expression of CD4 T‐cell subsets particularly persist in the terminal ileum of HIV‐positive patients despite cART

open access: yes, 2021
International audienceDespite its importance as an HIV anatomic sanctuary, little is known about the characteristics of the HIV reservoir in the terminal ileum (TI).
V Bondet   +41 more
core   +1 more source

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections

open access: yesFrontiers in Immunology, 2022
B cell lymphoma 2 (BCL-2) family proteins are involved in the mitochondrial apoptotic pathway and are key modulators of cellular lifespan, which is dysregulated during human immunodeficiency virus type 1 (HIV-1) and other viral infections, thereby ...
Monica D. Reece   +9 more
doaj   +1 more source

Mathematical modelling of internal HIV dynamics [PDF]

open access: yes, 2009
We study a mathematical model for the viral dynamics of HIV in an infected individual in the presence of HAART. The paper starts with a literature review and then formulates the basic mathematical model.
University of Strathclyde (Funder)   +3 more
core   +4 more sources

Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot Study

open access: yesViruses, 2021
Background: If analytical antiretroviral-treatment (ART) interruption (ATI) might significantly impact quantitative or qualitative peripheral-total HIV-DNA is still debated.
Rossana Scutari   +13 more
doaj   +1 more source

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection

open access: yesDisease Markers, 2022
Since the first discovery of human immunodeficiency virus 1 (HIV-1) in 1983, the targeted treatment, antiretroviral therapy (ART), has effectively limited the detected plasma viremia below a very low level and the technique has been improved rapidly.
Ruojing Bai, Shiyun Lv, Hao Wu, Lili Dai
openaire   +2 more sources

Animal models for studies of HIV-1 brain reservoirs

open access: yesJournal of Leukocyte Biology, 2022
AbstractThe HIV-1 often evades a robust antiretroviral-mediated immune response, leading to persistent infection within anatomically privileged sites including the CNS. Continuous low-level infection occurs in the presence of effective antiretroviral therapy (ART) in CD4+ T cells and mononuclear phagocytes (MP; monocytes, macrophages, microglia, and ...
Emiko Waight   +8 more
openaire   +2 more sources

A Dynamic Interplay of Circulating Extracellular Vesicles and Galectin-1 Reprograms Viral Latency during HIV-1 Infection

open access: yesmBio, 2022
Combined Antiretroviral therapy (cART) suppresses HIV replication but fails to eradicate the virus, which persists in a small pool of long-lived latently infected cells. Immune activation and residual inflammation during cART are considered to contribute
Julia Rubione   +20 more
doaj   +1 more source

Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy

open access: yesNature Communications, 2018
The latent HIV-1 reservoir is the key obstacle for curing HIV-1 infection, but the timepoint at which the HIV-1 reservoir is established is currently unclear. Here, Whitney et al.
James B. Whitney   +14 more
doaj   +1 more source

HIV-1 Genomes Are Enriched in Memory CD4 + T-Cells with Short Half-Lives

open access: yesmBio, 2021
The design of future HIV-1 curative therapies requires a more thorough understanding of the distribution of genetically intact HIV-1 within T-cell subsets as well as the cellular mechanisms that maintain this reservoir.
Vincent Morcilla   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy